Form 10-Q SYNERGY PHARMACEUTICALS, For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St headed for weekly gains as earnings season nears
- Oil falls as Trump comments on Iran talks ease supply concerns
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- CoreWeave stock drops on dilution fears and debt concerns
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
- Oracle and these 6 stocks are newest addition to Mizuho Top Picks list
- Anthropic launches cyber defense program for infrastructure and open-source
Synergy Pharma (SGYP) Misses Q2 EPS by 6c
August 10, 2015 4:34 PM EDTSynergy Pharma (NASDAQ: SGYP) reported Q2 EPS of ($0.34), $0.06 worse than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Synergy Pharma (SGYP) click here.
... More


